Key result
Mendelian randomization links 43 proteins to abdominal aortic aneurysm, highlighting PCSK9 and IL6R as targets.
Why the study?
Which plasma proteins have causal links to abdominal aortic aneurysm and mediate the effects of modifiable risk factors?
Observational
Which plasma proteins have causal links to abdominal aortic aneurysm and mediate the effects of modifiable risk factors?
Answers are grounded in this paper and cite their sources.
PCSK9, IL6R, ECM1, and ANGPTL4 are identified as potential high-priority protein therapeutic targets for abdominal aortic aneurysm.
BACKGROUND: Abdominal aortic aneurysm (AAA) is a severe aortic disease for which no pharmacological interventions have yet been developed. This investigation focused on identifying protein-based therapeutic targets and assessing how proteins mediate the interplay between modifiable risk factors and AAA development. METHODS: Causal inferences between plasma proteins and AAA were drawn using 2-sample Mendelian randomization, followed by comprehensive sensitivity testing, colocalization, and replication efforts. Further analyses included database interrogation, single-cell RNA data analysis, enrichment analysis, protein-protein interaction networks, and immunohistochemistry to map the tissue-specific expression of these proteins, their expression within AAA tissues, and their biological roles. Mediation Mendelian randomization was employed to evaluate the mediating effects of AAA-related proteins on the associations between AAA and 3 risk factors: hypertension, smoking, and obesity. RESULTS: A total of 43 proteins were identified as having causal links to AAA. Colocalization analysis pinpointed 13 proteins with strong evidence of colocalization with AAA. Of these, the causal involvement of 10 proteins was substantiated by external validation data. Consistent evidence for PCSK9 (proprotein convertase subtilisin/kexin type 9), IL6R (interleukin-6R), ECM1 (extracellular matrix protein 1), and ANGPTL4 (angiopoietin-related protein 4) was further validated through tissue immunohistochemistry and blood data. Moreover, Mendelian randomization analysis identified 10 proteins as mediators of the influence of hypertension, smoking, and obesity on AAA development. CONCLUSIONS: This analysis identifies 4 proteins (PCSK9, IL6R, ECM1, and ANGPTL4) as high-priority therapeutic targets for AAA and emphasizes the intermediary role of plasma proteins in linking hypertension, smoking, obesity, and AAA. Further investigations are needed to clarify the specific roles of these proteins in AAA pathology.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2025) conducted an observational in Abdominal aortic aneurysm. Plasma proteins (e.g., PCSK9, IL6R, ECM1, ANGPTL4) was evaluated on Causal links to abdominal aortic aneurysm. Mendelian randomization identified 43 proteins with causal links to abdominal aortic aneurysm, highlighting PCSK9, IL6R, ECM1, and ANGPTL4 as high-priority therapeutic targets.
Synapse has enriched 10 related papers. Consider them for comparative context: